By Dr John Walter Frew

Journal articles

Venugopal S; Yan W; Frew JW; Cohn HI; Tran K; Sturm M; Marinkovich P; Igawa S; Ishida-Yamamoto A; Murrell DF, 2012, 'INVESTIGATION OF CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB) THROUGH INTRADERMAL INJECTION OF ALLOGENEIC FIBROBLASTS RANDOMIZED AGAINST PLACEBO INJECTIONS OF SUSPENSION SOLUTION', WOUND REPAIR AND REGENERATION, 20, pp. A68 - A68, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sebaratnam DF; Hanna A; Chee S; Frew JW; Tan JCK; Venugopal SS; Rhodes LM; Welsh B; Nijsten T; Murrell DF, 2012, 'VALIDATION OF THE PSYCHOMETRIC PROPERTIES OF A QUALITY-OF-LIFE MEASURE SPECIFIC TO AUTOIMMUNE BULLOUS DISEASE', WOUND REPAIR AND REGENERATION, 20, pp. A65 - A65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Murrell DF, 2012, 'Corticosteroid Use in Autoimmune Blistering Diseases', Immunology and Allergy Clinics of North America, 32, pp. 283 - 294, http://dx.doi.org/10.1016/j.iac.2012.04.008

Sebaratnam DF; Frew JW; Davatchi F; Murrell DF, 2012, 'Quality-of-Life Measurement in Blistering Diseases', Dermatologic Clinics, 30, pp. 301 - 307, http://dx.doi.org/10.1016/j.det.2011.11.008

Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG, 2012, 'Variation in Radiotherapy Target Volume Definition, Dose to Organs at Risk and Clinical Target Volumes using Anatomic (Computed Tomography) versus Combined Anatomic and Molecular Imaging (Positron Emission Tomography/Computed Tomography): Intensity-modulated Radiotherapy Delivered using a Tomotherapy Hi Art Machine: Final Results of the VortigERN Study', CLINICAL ONCOLOGY, 24, pp. E173 - E179, http://dx.doi.org/10.1016/j.clon.2012.09.004

Frew JW; Lim SW; Klausseger A; Chow CW; Tran KT; Su J; Orchard D; Varigos G; Sawamura D; Nishie W; Shimizu H; Murrell DF, 2011, 'Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagen.', Australasian Journal of Dermatology, 52, pp. e1 - e4, http://dx.doi.org/10.1111/j.1440-0960.2010.00684.x

Frew J; Murrell DF, 2011, 'Corticosteroid Use in Autoimmune Blistering Diseases', Dermatologic Clinics, 29, pp. 535 - 544, http://dx.doi.org/10.1016/j.det.2011.06.004

Frew J; Murrell DF, 2011, 'Current Management Strategies in Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome)', Dermatologic Clinics, 29, pp. 607 - 612, http://dx.doi.org/10.1016/j.det.2011.06.016

Frew JW; Martin L; Murrell DF, 2011, 'Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus', Dermatologic Clinics, 29, pp. 599 - 606, http://dx.doi.org/10.1016/j.det.2011.07.001

Frew JW; Murrell DF, 2011, 'Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis', Dermatologic Clinics, 29, pp. 419 - 425, http://dx.doi.org/10.1016/j.det.2011.03.018

Gill SS; Frew J; Fry A; Adam J; Paleri V; Dobrowsky W; Chatterjee S; Kelly CG, 2011, 'Priorities for the Head and Neck Cancer Patient, their Companion and Members of the Multidisciplinary Team and Decision Regret', CLINICAL ONCOLOGY, 23, pp. 518 - 524, http://dx.doi.org/10.1016/j.clon.2011.03.014

Frew JW; Dopping-Hepenstal PJH; McGrath JA, 2010, 'Categorizing immunoflourescence mapping in epidermolysis bullosa with pyloric atresia: Use as a broad prognostic indicator', Australasian Journal of Dermatology, 51, pp. 212 - 214, http://dx.doi.org/10.1111/j.1440-0960.2010.00666.x

Venugopal SS; Yan H; Frew JW; Tran K; Melbourne W; Nelson J; Sturm M; Fogarty F; Marinkovich P; Igawa S; Ishida-Yamamoto A; Murrell DF, 2010, 'TRIAL OF FIBROBLAST CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA', WOUND REPAIR AND REGENERATION, 18, pp. A74 - A74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279454700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frew JW; Martin LK; Nijsten T; Murrell DF, 2010, 'Erratum: Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument (British Journal of Dermatology (2009) 161 (1323-1330))', British Journal of Dermatology, 162, pp. 701, http://dx.doi.org/10.1111/j.1365-2133.2010.09642.x

Purdie KJ; Pourreyron C; Fassihi H; Cepeda-Valdes R; Frew JW; Volz A; Weissenborn SJ; Pfister H; Proby CM; Bruckner-Tuderman L; Murrell DF; Salas-Alanis JC; McGrath JA; Leigh IM; Harwood CA; South AP, 2010, 'No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma', Journal of Investigative Dermatology, 130, pp. 2853 - 2855, http://dx.doi.org/10.1038/jid.2010.243

Frew JW; Murrell DF, 2010, 'Quality of Life Measurements in Epidermolysis Bullosa: Tools for Clinical Research and Patient Care', Dermatologic Clinics, 28, pp. 185 - 190, http://dx.doi.org/10.1016/j.det.2009.10.019

Frew JW; Martin LK; Nijsten T; Murrell DF, 2009, 'Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument', British Journal of Dermatology, 161, pp. 1323 - 1330, http://dx.doi.org/10.1111/j.1365-2133.2009.09347.x

Frew JW, 2009, 'Performing surgery with a single electron: Electrosurgery and quantum mechanics', ANZ Journal of Surgery, 79, pp. 680 - 682, http://dx.doi.org/10.1111/j.1445-2197.2009.05051.x

Nading M; Lahmar J; Frew J; Ghionis N; Hanley M; Welch A; Murrell DF, 2009, 'A ski and adventure camp for young patients with severe forms of epidermolysis bullosa', Journal of the American Academy of Dermatology, 61, pp. 508 - 511

Frew J; Martin L; Murrell DF, 2008, 'Development of a quality of life measure specific for epidermolysis bullosa', Journal of Investigative Dermatology, 128, pp. S80 - S80

Frew J; Martin L; Murrell DF, 2008, 'Quality of life evaluation in epidermolysis bullosa', Journal of the American Academy of Dermatology, 58, pp. AB81 - AB81

Frew J; Martin L; Murrell DF, 2008, 'Quality of life evaluation in epidermolysis bullosa: Development of the QOLEB questionnaire', Journal of Investigative Dermatology, 128, pp. 1607 - 1607

Frew J; Mallick U; Perros P, 2007, 'A patient with asymmetric parotid uptake on a diagnostic iodine-131 scan during thyroid cancer follow-up', THYROID, 17, pp. 801 - 802, http://dx.doi.org/10.1089/thy.2006.0309

Henderson NC; Pollock KJ; Frew J; Mackinnon AC; Flavell RA; Davis RJ; Sethi T; Simpson KJ, 2007, 'Critical role of c-jun (NH2) terminal kinase in paracetamol-induced acute liver failure', GUT, 56, pp. 982 - 990, http://dx.doi.org/10.1136/gut.2006.104372

Frew J; Mort F, 1907, 'SOUTHERN HIGHLANDS FROM GLASGOW', SCOTTISH GEOGRAPHICAL MAGAZINE, 23, pp. 367 - 372, http://dx.doi.org/10.1080/00369220708733767

Frew J; Mort F, 1906, 'THE SOUTHERN HIGHLANDS FROM DUMGOYN', SCOTTISH GEOGRAPHICAL MAGAZINE, 22, pp. 322 - 324, http://dx.doi.org/10.1080/14702540608554666

Mort F; Frew J, 1906, 'THE SOUTHERN HIGHLANDS FROM GOUROCK', SCOTTISH GEOGRAPHICAL MAGAZINE, 22, pp. 435 - 438, http://dx.doi.org/10.1080/00369220608733658

Conference Papers

Islam R; Frew J; Kok C; Gupta M, 2026, 'New-Onset Vitiligo and Change in Disease Status Following COVID-19 Vaccination and COVID-19 Infection—An Online Survey', in Australasian Journal of Dermatology, pp. 109 - 113, http://dx.doi.org/10.1111/ajd.70027

Orenstein LAV; Shi VY; Lev-Tov H; Prens E; Ingram JR; Frew JW; Fujita H; Rolleri R; Lambert J; Crater C; Bechara FG; Davis L; Szepietowski JC, 2025, '2-year Impact of Bimekizumab on HSSQ Skin Pain in moderate to severe HS: Data from BE HEARD EXT', in JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, WILEY, pp. 133 - 133

Orenstein LA; Shi VY; Lev-Tov H; Prens E; Ingram JR; Frew JW; Fujita H; Rolleri R; Lambert J; Crater C; Bechara FG; Davis L; Szepietowski JC, 2025, '2-year impact of bimekizumab on HSSQ skin pain in moderate to severe HS: data from BE HEARD EXT', in JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, WILEY

Tzellos T; Sayed CJ; Gottlieb AB; Becherel P-A; Kirby B; Asai J; Frew JW; Pansar I; Tilt N; Rolleri R; Porter ML, 2025, 'Bimekizumab impact on draining tunnel reduction over 2 years in moderate to severe hidradenitis suppurativa: Results from BE HEARD EXT', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB137 - AB137

Sayed CJ; Kirby B; Frew JW; Porter ML; Ingram JR; Prens E; Charrow AP; Gooderham MJ; Savage L; Reich K; Bechara FG, 2025, 'IHS4-100 responses and other IHS4 outcomes with the IL-17A-and IL-17F-inhibiting Nanobody sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 24 results from the Phase 2 MIRA trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB221 - AB221

Frew J; Flora A; Pham J; Woods J; Radzieta M; Dickson H; Malone M, 2025, 'The Clinical and Molecular Response of Pyoderma Gangrenosum to Interleukin 23 Blockade: Result from a proof-of-concept open-label clinical trial', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, pp. AB313 - AB313

van der Zee HH; Kirby B; Bechara FG; Jemec GBE; Frew JW; Rolleri R; Joshi P; Pansar I; Tilt N; Sayed CJ, 2024, 'Bimekizumab impact on lesion count by anatomical region in moderate to severe hidradenitis suppurativa: Results to week 48 from BE HEARD I & II', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Zouboulis CC; Kirby JS; Tzellos T; Khattri S; Alavi A; Podda M; del Marmol V; Spelman L; Rolleri R; Joshi P; Davis L; Pansar I; Frew JW, 2024, 'IHS4 outcomes with bimekizumab in patients with moderate to severe hidradenitis suppurativa: Pooled results from the BE HEARD I & II phase 3 trials', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Kirby B; Frew JW; Porter MJ; Bechara FG; Ingram JR; Prens EP; Charrow AP; Sayed CJ; Brennan N; Godwood A; Attar N; Cullen E; Reich K, 2024, 'The IL-17A-and IL-17F-inhibiting Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS): Week 12 International Hidradenitis Suppurativa Severity Score System (IHS4) results from the phase 2 MIRA trial', in EXPERIMENTAL DERMATOLOGY, WILEY, FRANCE, Lyon, presented at 13th European Hidradenitis Suppurativa Conference (EHSF), FRANCE, Lyon, 07 February 2024 - 09 February 2024

Zarroug M; Shaheen A; Mohammed A; Elgendy M; Burns A; AlHilali M; Vanderputten M; Azzabi A; Chandler R; Frew J; Hayhurst H; Jackson M; Pedley I; Pearson R; Jiang X, 2023, 'Brain directed therapy followed by systemic treatment in metastatic renal cell carcinoma', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, AUSTRIA, Vienna, pp. S894 - S894, presented at Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), AUSTRIA, Vienna, 12 May 2023 - 16 May 2023

Flora A; Jepsen R; Kozera E; Woods J; Cains G; Radzieta M; Malone M; Frew JW, 2023, 'Human dermal fibroblasts and mast cell populations are altered in hidradenitis suppurativa, with epithelial-mesenchymal-transition signals ameliorated by spleen tyrosine kinase antagonism.', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Tokyo, pp. S227 - S227, presented at 1st International Societies for Investigative Dermatology Meeting, JAPAN, Tokyo, 12 May 2023 - 13 May 2023

Paton E; Fogarty G; Murrell D; Frew J, 2023, 'A proposed phase I trial evaluating Volumetric Modulated Arc Therapy ( VMAT) radiotherapy (RT) in patients with recalcitrant Hidradenitis Suppurativa (HS)', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 51 - 52

Kozera E; Flora A; Stewart T; Gill K; De la Vega MA; Frew J, 2023, 'Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with malassezia-specific immunoglobulin e levels mirroring cli', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 12 - 12

Flora A; Frew J, 2023, 'Hidradenitis Suppurativa: Clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism -A Prospective Cohort Study', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 15 - 15

Pham J; Frew J, 2023, 'Resident cutaneous memory T-cells: A review of their role in modulating chronic inflammatory dermatoses and potential as therapeutic targets', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 80 - 81

Jepsen R; Flora A; Kozera E; Frew JW, 2023, 'SYK antagonism in hidradenitis suppurativa demonstrates clinical efficacy with grearter response in B-cell predominant disease: Results of a open-label, proof-of-concept phase 2 clinical trial', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. B15 - B15

Flora A; Frew J; Woods J, 2023, 'Tick bite induced meat allergy: A presentation of two cases and review of the literature', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 57 - 58

Pham JP; Glasenhardt K; Garg A; Frew JW, 2022, 'Interpretation of comorbidity risk in hidradenitis suppurativa: comparing odds ratio and ‘number needed to be exposed’', in Journal of the European Academy of Dermatology and Venereology, pp. e1004 - e1006, http://dx.doi.org/10.1111/jdv.18403

Kuhnl A; Mikhaeel G; Kirkwood AA; Menne TF; Frew J; Tholouli E; Patel A; Besley CM; Beasley MJ; Latif AL; O'Rourke N; Nicholson E; Alexander E; Chaganti S; Stevens AM; Marzolini MAV; Johnson RJ; Sanderson R; Sivabalasingham S; Roddie C, 2021, 'Radiotherapy Bridging in Patients With R/R High-Grade Lymphoma Receiving CD19 CAR-T in the UK', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, pp. S130 - S130

Tree AC; Hall E; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Brand DH; Chan A; Dayes IS; Brown S; Pugh J; Burnett S; Dufton A; Griffin C; Mahmud M; Naismith O; van As N, 2021, 'Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S197 - S197, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709667200220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jackson M; Hannaway N; Burns A; Pearson R; Chandler R; Frew J; Azzabi A; Jiang X, 2021, 'High dose palliative radiotherapy in bladder cancer - A single centre experience from the UK', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S1152 - S1153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000709667203302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Navrazhina K; Renert-Yuval Y; Frew J; Grand D; Garcet S; Krueger JG, 2021, 'Blood analysis uncovers novel inflammatory, oncologic and cardiovascular biomarkers in psoriasis and Hidradenitis Suppurativa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. S122 - S122, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800701&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams S; Navrazhina K; Frew J; Garcet S; Krueger JG, 2021, 'Vascularization in the deep dermis of hidradenitis suppurativa lesions', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, pp. S121 - S121, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000641872800698&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page